[artículo] 
inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 137-147

Título :	Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia
Tipo de documento:	texto impreso
Autores:	Maurizio Fava, Autor ; Sharon L. Hoog, Autor ; Rajinder A. Judge, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 137-147
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antidepresivos, Trastorno Depresivo Mayor, Fluoxetina, Paroxetina, Sertralina, Trastornos del sueño.
Resumen:	This study assessed whether fluoxetine, sertraline, and paroxetine differ in efficacy and tolerability in depressed patients and the impact of baseline insomnia on outcomes. Patients (N = 284) with DSM-IV major depressive disorder were randomly assigned in a double-blind fashion to fluoxetine, paroxetine, or sertraline for 10 to 16 weeks of treatment.
Link:	./index.php?lvl=notice_display&id=31078

[artículo] Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia [texto impreso] / Maurizio Fava, Autor ; Sharon L. Hoog, Autor ; Rajinder A. Judge, Autor . - 2023 . - pp. 137-147.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 137-147

Palabras clave:	Antidepresivos, Trastorno Depresivo Mayor, Fluoxetina, Paroxetina, Sertralina, Trastornos del sueño.
Resumen:	This study assessed whether fluoxetine, sertraline, and paroxetine differ in efficacy and tolerability in depressed patients and the impact of baseline insomnia on outcomes. Patients (N = 284) with DSM-IV major depressive disorder were randomly assigned in a double-blind fashion to fluoxetine, paroxetine, or sertraline for 10 to 16 weeks of treatment.
Link:	./index.php?lvl=notice_display&id=31078